In 1968, he came to the National Institutes of Health (NIH) as a clinical associate in the Laboratory of Clinical Investigation (LCI) in NIAID.
He played a significant role in the early 2000s in creating the President's Emergency Plan for AIDS Relief[REF] and in driving development of biodefense drugs and vaccines following the 9/11 terrorist attacks [REF].